NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Tuesday it has increased the amount of convertible senior notes it is offering and has priced them.

Cepheid raised the offering to $300 million from $250 million announced earlier this week and has granted the initial purchasers an option to purchase an additional $45 million of notes to cover any overallotments. Morgan Stanley and Jefferies are the initial purchasers of the notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.